Carna Biosciences Inc. | Income Statement
Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
Sales/Revenue
771
612
1,569
812
658
Cost of Goods Sold (COGS) incl. D&A
241
269
270
254
223
Gross Income
530
342
1,300
557
435
SG&A Expense
769
977
827
981
1,134
Unusual Expense
3
238
6
26
22
Non Operating Income/Expense
26
30
22
169
6
Interest Expense
2
2
2
8
7
Pretax Income
279
845
486
289
733
Consolidated Net Income
282
847
456
290
737
Net Income
282
847
456
290
737
Net Income After Extraordinaries
282
847
456
290
737
Net Income Available to Common
282
847
456
290
737
EPS (Basic)
36.59
102.18
52.61
31.64
78.53
Basic Shares Outstanding
8
8
9
9
9
EPS (Diluted)
36.59
102.18
50.05
31.64
78.53
Diluted Shares Outstanding
8
8
9
9
9
EBITDA
201
567
492
402
687
Non-Operating Interest Income
-
-
-
-
-
About Carna Biosciences
View Profile
